SHC Sotera Health Company
HealthcareAs of 2026-05-25
Valuation
View DetailsP/E (TTM)
53.41
PEG
0.71
P/B
7.17
P/S
3.76
EV/EBITDA
12.89
DCF Value
$-3.05
FCF Yield
2.1%
Div Yield
0.0%
Margins & Returns
Gross Margin
55.0%
Operating Margin
35.5%
Net Margin
9.9%
ROE
20.6%
ROA
3.6%
ROIC
8.0%
Financials
View All| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q1 null | $280.0M | $26.6M | $— |
| Q4 null | $303.4M | $34.8M | $— |
| FY null | $1.16B | $77.9M | $— |
| Q3 null | $311.3M | $48.4M | $— |
Analyst Ratings
View AllConsensus
Buy
Target (Consensus)
$22.00
Target (Median)
$24.00
Target Range
$18.00 - $24.00
Trading Activity
Insider Trades
View AllCompany Info
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Country
US
Exchange
—
Beta
1.82
Sotera Health Company provides sterilization, and lab testing and advisory services in the United States, Canada, Europe, and internationally. The company's sterilization services include gamma and electron beam irradiation, and EO processing; Nelson Labs comprise microbiological and analytical chemistry testing; and advisory services for medical device and biopharmaceutical industries. It serves medical devices; pharmaceuticals; food and agricultural products; and commercial, advanced, and specialty application industries. The company was formerly known as Sotera Health Topco, Inc. and changed its name to Sotera Health Company in October 2020. Sotera Health Company was incorporated in 2017 and is headquartered in Broadview Heights, Ohio.